Outlook Therapeutics, Inc. (OTLK)

Outlook Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Year Ending	TTM	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Cash & Equivalents	47.23	23.39	17.4	14.48	12.54	8.02
Cash & Cash Equivalents	47.23	23.39	17.4	14.48	12.54	8.02
Cash Growth	8.25%	34.46%	20.17%	15.49%	56.40%	366.73%
Other Current Assets	10.56	7.59	10.12	7.03	5.41	5.49
Total Current Assets	57.79	30.98	27.52	21.51	17.94	13.5
Property, Plant & Equipment	0	0.03	0.07	0.28	0.49	3.18
Long-Term Investments	0.77	0.79	0.8	0.85	0	0
Other Long-Term Assets	0.47	0.5	0.13	0.17	1.29	0.46
Total Long-Term Assets	1.24	1.32	1.01	1.3	1.79	3.63
Total Assets	59.03	32.3	28.53	22.81	19.73	17.13
Accounts Payable	4.36	6.57	3.49	2.2	2.39	2.28
Current Debt	44.75	35.56	10.95	0.97	0.27	7.92
Other Current Liabilities	4.97	4.6	5.28	3.58	13.23	10.09
Total Current Liabilities	54.08	46.73	19.73	6.75	15.89	20.29
Long-Term Debt	0	0	0	10.93	0.95	3.42
Other Long-Term Liabilities	139.18	0.01	0.06	0.52	0.07	4.2
Total Long-Term Liabilities	139.18	0.01	0.06	11.45	1.02	7.61
Total Liabilities	193.26	46.74	19.79	18.2	16.91	27.9
Total Debt	44.75	35.56	10.96	11.9	1.21	11.33
Debt Growth	40.54%	224.47%	-7.93%	880.24%	-89.29%	-34.56%
Retained Earnings	-593.39	-467.92	-408.94	-342.88	-289.72	-254.48
Shareholders' Equity	-134.24	-14.44	8.74	4.61	2.83	-16.13
Net Cash / Debt	2.48	-12.16	6.44	2.57	11.32	-3.32
Net Cash / Debt Growth	-78.93%	-	150.06%	-77.26%	-	-
Net Cash Per Share	0.17	-0.97	0.61	0.34	3.12	-3.65
Working Capital	3.71	-15.75	7.79	14.76	2.06	-6.79
Book Value Per Share	-9.41	-1.15	0.82	0.60	0.78	-17.73

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).